Nanolive hosts this event on “Non-invasive, high content live cell assays to increase translational relevance of in vitro drug development of biologics and small molecules”.
In this webinar, we present the following use-cases of our immuno-oncology and cytotoxicity assays from industry-leading biopharma companies to test toxicity, selectivity, uptake and expression of different targeted therapies.
- Immune cell therapeutics:
- Bispecific antibody screening in a T cell-target cell co-culture (Light Chain Bioscience)
- Drug selectivity and cytotoxicity:
- mRNA expression and cytotoxicity (TRON)
- Drug selectivity in co-cultures: senolytics (dsm-firmenich)
- Measuring particle uptake (bit.bio)
This webinar lasts 20 to 25 minutes.
Read our latest news
Simplifying drug delivery assessment: Industry perspectives
Optimization of drug delivery systems can become slow, resource intensive, and reliant on incomplete information. With one assay, Nanolive monitors the complete dynamics of drug delivery, reducing phototoxicity from labels and helping teams identify where delivery succeeds or fails.
Webinar – Investigating nanoparticle delivery with label-free live cell imaging
Watch our latest webinar, where Elizabeth Nelson shares research performed at the MIT Koch Institute for Integrative Cancer Research, demonstrating a live-cell imaging workflow to quantify the dynamic uptake of nanoparticles…
Move beyond endpoints with dynamic EC50
Discover case study data for a dynamic approach to monitoring EC50 to gain more accurate insights into drug function.